Premium
P3‐462: Aspects related to the burden of caregivers of dementia patients in a tertiary outpatient clinic
Author(s) -
Bressan Lúcia A.,
Balieiro Ari Pedro,
Rodrigues Rosalina A.P.,
Franco Beatriz B.,
Silva -Filho José Humberto,
Vale Francisco A.C.
Publication year - 2008
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2008.05.2033
Subject(s) - dementia , sadness , feeling , medicine , disease , empathy , family medicine , psychology , psychiatry , social psychology , anger , pathology
parallel group study of donepezil vs. placebo, data will be presented on goals set at baseline by up to 1600 caregivers and patients with moderate to severe DAT (MMSE 1-20). The study is global, with over 200 sites across North America, South America, Europe, Asia, Oceania and South Africa. At study initiation the caregiver and patient are separately asked to specify up to four goals. First, dementia-related symptoms in which improvement is desired are defined. These are then defined in plain language, and plausibly better and worse states are established and recorded. The resulting scale, scored from 0 at baseline, ranges from 2 (“much better” [than baseline])” to -2 (“much worse”). Results: The analyses from this large, unique, global dataset will include: proportions of patients per MMSE grouping who are able to define and set goals at baseline; concordance between caregiver and patient-set goals; influence on caregiver goal of caregiver gender and MMSE of the patient. Conclusions: The results may have the potential for better understanding of the expectations of patients and their caregivers from pharmacological intervention in moderate to severe DAT.